Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:35 PM
Ignite Modification Date:
2025-12-24 @ 1:35 PM
NCT ID:
NCT00027495
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Healthy men and women age 18 and over
PATIENT CHARACTERISTICS:
Age:
* 18 and over
Performance status:
* Not specified
Life expectancy:
* Not specified
Hematopoietic:
* WBC greater than 4,000/mm3
* Hemoglobin greater than 12 g/dL
* Platelet count greater than 120,000/mm3
Hepatic:
* ALT/AST less than 1.5 times upper limit of normal (ULN)
* Alkaline phosphatase less than 1.5 times ULN
* Bilirubin less than 1.5 mg/dL
Renal:
* Creatinine less than 1.7 mg/dL
Other:
* Not pregnant or nursing
* Negative pregnancy test
* Fertile patients must use effective contraception
* No prior cancer except surgically resected basal cell or squamous cell skin cancer
* No history of peptic ulcer disease, gastrointestinal bleeding from gastric or duodenal ulcers, or gastrin secreting tumors
* No history of unreliability or noncompliance (missing pretreatment appointment more than twice)
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* Not specified
Chemotherapy:
* Not specified
Endocrine therapy:
* At least 14 days since prior steroids
Radiotherapy:
* Not specified
Surgery:
* Not specified
Other:
* At least 14 days since prior curcumin (turmeric) rich foods
* At least 14 days since prior nonsteroidal antiinflammatory drugs (NSAIDs)
* No chronic medications (i.e., daily for more than 28 days) except for oral contraceptives
* No concurrent coumadin or other anticoagulants
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00027495
Study Brief:
Protocol Section:
NCT00027495